During the last session, Kairos Pharma Ltd (AMEX:KAPA)’s traded shares were 0.28 million. The 52-week high for the KAPA share is $4.00, that puts it down -463.38 from that peak though still a striking 43.66% gain since the share price plummeted to a 52-week low of $0.40. The company’s market capitalization is $11.96M, and the average intraday trading volume over the past 10 days was 0.55 million shares, and the average trade volume was 878.72K shares over the past three months.
Kairos Pharma Ltd (AMEX:KAPA) trade information
Kairos Pharma Ltd (KAPA) registered a -0.14% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -0.14% in intraday trading to $0.71, hitting a weekly high. The stock’s 5-day price performance is 9.06%, and it has moved by 30.51% in 30 days. Based on these gigs, the overall price performance for the year is -53.29%. The short interest in Kairos Pharma Ltd (AMEX:KAPA) is 0.19 million shares and it means that shorts have 0.12 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -23.37%. While earnings are projected to return 7.25% in 2025, the next five years will return -24.45% per annum.
KAPA Dividends
Kairos Pharma Ltd is due to release its next quarterly earnings on 2025-May-14. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Kairos Pharma Ltd (AMEX:KAPA)’s Major holders
Kairos Pharma Ltd insiders own 47.25% of total outstanding shares while institutional holders control 9.36%, with the float percentage being 17.75%.
Also, the Mutual Funds coming in first place with the largest holdings of Kairos Pharma Ltd (KAPA) shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . Data provided on May 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Extended Market Index Fund owns about 16.76 shares. This amounts to just over 0.10 percent of the company’s overall shares, with a $11897.0 market value. The same data shows that the other fund manager holds slightly less at 5.05, or about 0.03% of the stock, which is worth about $3583.0.